Palantir

Palantir 2,500% Surge: Bulls Struggle to Justify the Company’s Valuation

Palantir has captured attention in the stock market with its massive growth. The company’s stock has risen nearly 150% this year alone. Since its debut in 2021, Palantir shares have surged almost 2,500%. This rapid climb has pushed Palantir’s valuation to extreme levels. As of August 8, the stock closed at $186.96. After hours, it…

Digital Brands

Digital Brands Signs $11.225 Million Private Placement Deal with Select Investors

Digital Brands Group has signed a key deal. They raised $11.225 million through a private placement. This move gives them fresh cash for growth. The deal closed on August 8, 2025. They announced it the next day. It involves select investors who bought preferred stock. This funding helps Digital Brands in the stock market. It…

TravelZoo

Travelzoo (NASDAQ: TZOO) and the Growing Value of Subscription-Based Travel Deal Platforms

The way we plan trips is changing fast. In the past, we searched dozens of sites to find good deals. Now, we want trusted sources to do the hard work for us. That’s where subscription-based travel platforms fit in. Travelzoo has been a leader in this space for years. It curates high-quality travel offers and…

Embecta Corp

Embecta Corp Q3 2025 Outperformance: A Key Opportunity for Strategic Re-Rating Amid Margin Stability

We witnessed Embecta Corp deliver a standout performance in Q3 2025, surpassing market expectations with robust financials. The company reported an adjusted EPS of $1.12, beating the consensus estimate of $0.77, fueled by an impressive 44.3% EBITDA margin and 8.4% revenue growth. This success positions Embecta Corp as a compelling opportunity for investors seeking long-term…

Oncolytics Biotech

Oncolytics Biotech: A Promising Leader in the Next-Gen Immunotherapy Landscape

We see Oncolytics Biotech as a rising star in the immunotherapy field, pushing boundaries with its innovative drug, pelareorep. This company targets tough cancers like pancreatic ductal adenocarcinoma, offering hope where treatments are scarce. Its strong trial results and strategic planning make it a standout in the biotech sector. The immunotherapy landscape is evolving fast,…

Etoiles Capital Group announces US$5.6M IPO pricing on NASDAQ

Etoiles Capital Group Announces US$5.6 Million IPO Pricing

Etoiles Capital Group, a Hong Kong-based financial services firm, has priced its initial public offering at US $4.00 per share, raising US $5.6 million before expenses. The 1,400,000 Class A ordinary shares begin trading on the Nasdaq Capital Market under the ticker EFTY starting August 8, 2025 with the offering expected to close on or…

TSMC

TSMC Reports 26% Sales Growth in July Fueled by AI Chip Demand

Taiwan Semiconductor Manufacturing Company, or TSMC, reported a strong jump in its sales for July 2025. The company’s revenue grew by 26% compared to the same month last year. This is a big increase for one of the world’s top chip makers. The main reason for this boost is the rising demand for AI chips….

Intel CEO

Intel CEO Responds to Trump Demand, Works with Administration

In recent months, there has been a lot of talk about how big tech companies should help the country grow. One of the biggest names in technology, Intel, found itself in the spotlight when former President Trump made a clear demand. He wanted Intel to boost its manufacturing in the United States and create more…

Stock Market

Stock Market Today: Dow Slides, Nasdaq Hits Record on Tariff News

The stock market gave us a mixed picture today. The Dow slipped into the red, while the Nasdaq climbed to a new all-time high. The reason? Fresh tariff news that sent shockwaves across Wall Street. We saw investors react fast. Some rushed to buy tech stocks, hoping to ride the wave. Others pulled back from…